TABLE 1.
Study Subjects’ Demographics in Post-hospitalization and Non-hospitalized Neuro-PASC Patients
| Overall | Post-hospitalization Neuro-PASC (PNP) |
Non-hospitalized Neuro-PASC (NNP) |
p-Value | |
|---|---|---|---|---|
| n | 600 | 100 | 500 | |
| Age, years (mean (1 SD)) | 46.4 (14.0) | 53.9 (14.7) | 44.9 (13.4) | <0.0001 |
| Gender | 0.14 | |||
| Male, n (%) | 213 (35) | 42 (42) | 171 (34) | |
| Female, n (%) | 387 (65) | 58 (58) | 329 (65.8) | |
| Race, n (%) | 0.004 | |||
| White | 447 (74.5) | 62 (62) | 385 (77.0) | |
| Black or African American | 59 (9.8) | 18 (18) | 41 (8.2) | |
| Asian | 22 (3.7) | 3 (3) | 19 (3.8) | |
| American Indian/Alaskan Native | 2 (0.3) | 1 (1) | 1 (0.2) | |
| Native Hawaiian/Other Pacific Islander | 2 (0.3) | 1 (1) | 1 (0.2) | |
| Other | 47 (7.8) | 10 (10) | 37 (7.4) | |
| Multiracial | 6 (1.0) | 3 (3) | 3 (0.6) | |
| Not specified | 15 (2.5) | 2 (2) | 13 (2.6) | |
| Ethnicity, n (%) | 0.11 | |||
| Not Hispanic or Latino | 504 (84.0) | 80 (80) | 424 (84.8) | |
| Hispanic or Latino | 80 (13.3) | 19 (19) | 61 (12.2) | |
| Not specified | 16 (2.7) | 1 (1) | 15 (3) | |
| Visit type, n (%) | 0.51 | |||
| In person | 320 (53.3) | 50 (50) | 270 (54) | |
| Televisit | 280 (46.7) | 50 (50) | 230 (46) | |
| SARS-CoV-2 RT-PCR, n (%) | 0.02 | |||
| Positive | 532 (88.7) | 96 (96) | 436 (87.2) | |
| Negative | 39 (6.5) | 4(4) | 35 (7) | |
| Not Performed | 29 (4.8) | 0 (0) | 29 (5.8) | |
| SARS-CoV-2 serology, n (%) | 0.04 | |||
| Positive | 266 (44.3) | 54 (54) | 212 (42.4) | |
| Negative | 37 (6.2) | 2 (2) | 35 (7) | |
| Not Performed | 297 (49.5) | 44 (44) | 253 (50.6) | |
| Positive RT-PCR and serology, n (%) | 198 (33) | 50 (50) | 148 (29.6) | 0.0001 |
| Either RT-PCR or serology positive, n (%) | 600 (100) | 100 (100) | 500 (100) | 1 |
| SARS-CoV-2 vaccination, n (%) | 0.09 | |||
| Yes | 257 (42.8) | 33 (33) | 224 (44.8) | |
| No | 309 (51.5) | 61 (61) | 248 (49.6) | |
| Unknown | 34 (5.7) | 6 (6) | 28 (5.6) |